Vaxxinity Inc - Ordinary Shares - Class A

NASDAQ:VAXX  
4.40
+0.31 (+7.58%)
Earnings Announcements

Vaxxinity Reports First Quarter 2022 Financial Results

Published: 05/09/2022 13:47 GMT
Vaxxinity Inc - Ordinary Shares - Class A (VAXX) - Vaxxinity Reports First Quarter 2022 Financial Results and Provides Corporate Updates.
Vaxxinity Inc - As of March 31, 2022, Cash and Cash Equivalents Were $124.8 Million.
Vaxxinity Inc - Qtry Loss per Share $0.15.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.38

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.32

More details on our Analysts Page.